Application of assisted reproductive technology programs in a female patient with systemic lupus erythematosus and antiphospholipid syndrome


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Background. Patients with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) often face the problems related to their reproductive function; in this connection many patients undergo assisted reproductive technology (ART) programs. However, the challenges in implementing the ARTprograms in this group of patients include diminished ovarian reserve due to the treatment received, as well as the risk of an exacerbation of the underlying disease and thrombosis. Case report. This describes a case of a successfully implemented in vitro fertilization (IVF) program, followed by embryo cryopreservation in the patient with severe SLE and APS and a family obstetric/gynecological history. Conclusion. The authors describe the stages of the IVF program in the modified clinical and embryological protocol for ovarian stimulation with gonadotropin-releasing hormone antagonists and subsequent embryo cryopreservation, as well as the measures to prevent complications of the underlying disease.

Толық мәтін

Рұқсат жабық

Авторлар туралы

N. Kosheleva

A.A. Nasonova Research Institute of Rheumatology, Ministry of Science and Higher Education of Russia

Email: nadkosheleva@yandex.ru
scientific researcher of the Laboratory of Vascular Rheumatology 34A, Kashirskoye Shosse, Moscow, 115522, Russian Federation

S. Perminova

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: perisvet@list.ru
MD, PhD, Leading researcher of 1-st gynecology department 4, Oparina str., Moscow, 117997, Russian Federation

G. Vlasova

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: galinavlasova089@gmail.com
graduate student of 1-st gynecology department 4, Oparina str., Moscow, 117997, Russian Federation

A. Kirillova

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: a_kozyreva@oparina4.ru
PhD, Senior 4, Oparina str., Moscow, 117997, Russian Federation. 18

Әдебиет тізімі

  1. Оstensen M. Sexual and reproductive health in rheumatic disease. Nat. Rev. Rheumatol. 2017; 13(8): 85-93. https://dx.doi.org/10.1038/nrrheum.2017.102.
  2. Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Arthritis Rheum. 1999; 42(9): 1785-96. https://dx.doi.org/10.1002/1529-0131 (199909)42:9< 1785: :AID-ANR1>3.0.CO;2-#.
  3. Baker W.F. Jr, Bick R.L. The clinical spectrum of antiphospholipid syndrome. Hematol. Oncol. Clin. North Am. 2008; 22(1): 33-52, v-vi. https://dx.doi. org/10.1016/j.hoc.2007.10.007.
  4. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N. Engl. J. Med. 2008; 358(9): 929-39. https://dx.doi.org/10.1056/NEJMra071297.
  5. Насонов Е.Л., ред. Ревматология. Российские клинические рекомендации. М.: ГЭОТАР-Медиа; 2017. 456 с. [Nasonov E.L., ed. Revmatologiya. Rossiiskie klinicheskie rekomendatsii. Moscow: GEOTAR-Media; 2017. 456p. (in Russian).]
  6. Lahita R.G. The role of sex hormones in systemic lupus erythematosus. Curr. Opin. Rheumatol. 1999;11(5): 352-6. https://dx.doi.org/10.1097/00002281-199909000-00005.
  7. Oktem O., Hande Y., Hale B., Bulent U. Reproductive aspects of systemic lupus erythematosus. J. Reprod. Immunol. 2016; 117: 57-65. https://dx.doi. org/10.1016/j.jri.2016.07.001.
  8. Lee T.P., Chiang B.L. Sex differences in spontaneous versus induced animal models of autoimmunity. Autoimmun. Rev. 2012; 11(6-7): A422-9. https:// dx.doi.org/10.1016/j.autrev.2011.11.020.
  9. Andreoli L., Crisafulli F., Tincani A. Pregnancy and reproductive aspects of systemic lupus erythematosus. Curr. Opin. Rheumatol. 2017; 29(5): 473-9. https://dx.doi.org/10.1097/BOR.0000000000000415.
  10. Clowse M.E., Chakravarty E., Costenbader K.H., Chambers C., Michaud K. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res. (Hoboken). 2012; 64(5): 668-74. https://dx.doi.org/10.1002/ acr.21593.
  11. Lawrenz B., Henes J., Henes M., Neunhoeffer E., Schmalzing M., Fehm T. et al. Impact of systemic lupus erythematosus on ovarian reserve in premenopausal women: evaluation by using anti-Muellerian hormone. Lupus. 2011; 20(11): 1193-7. https://dx.doi.org/10.1177/0961203311409272.
  12. Medeiros P.B., Febronio M. V, Bonfa E., Borba E.F., Takiuti A.D., Silva C.A. Menstrual and hormonal alterations in juvenile systemic lupus erythematosus. Lupus. 2009;18(1): 38-43. https://dx.doi.org/10.1177/0961203308094652.
  13. LaBarbera A.R., Miller M.M., Ober C., Rebar R.W. Autoimmune etiology in premature ovarian failure. Am. J. Reprod. Immunol. Microbiol. 1988; 16(3): 115-22.
  14. Blanco-Favela F., Quintal-Alvarez G., Leanos-Miranda A. Association between prolactin and disease activity in systemic lupus erythematosus. Influence of statistical power. J. Rheumatol. 1999; 26(1): 55-9.
  15. Silva C.A., Deen M.E., Febronio M.V., Oliveira S.K., Terreri M.T., Sacchetti, S.B. et al. Hormone profile in juvenile systemic lupus erythematosus with previous or current amenorrhea. Rheumatol. Int. 2011; 31(8): 1037-43. https://dx.doi. org/10.1007/s00296-010-1389-2.
  16. Ioannidis J.P., Katsifis G.E., Tzioufas A.G., Moutsopoulos H.M. Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J. Rheumatol. 2002; 29(10): 2129-35.
  17. Oktem O., Oktay K. A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve. Cancer Res. 2007;67(21): 10159-62. https://dx.doi.org/10.1158/0008-5472.CAN-07-2042.
  18. Crawford N.M., Steiner A.Z. Age-related infertility. Obstet. Gynecol. Clin. North Am. 2015; 42(1): 15-25. https://dx.doi.org/10.1016/j.ogc.2014.09.005.
  19. Levine A.B., Lockshin M.D. Assisted reproductive technology in SLE and APS. Lupus. 2014; 23(12): 1239-41. https://dx.doi.org/10.1177/ 0961203314527370.
  20. Reynaud Q., Lega J.C., Mismetti P., Chapelle C., Wahl D., Cathebras P., Laporte S. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis. Autoimmun Rev. 2014; 13(6): 595-608. https://dx.doi. org/10.1016/j.autrev.2013.11.004.
  21. Bellver J., Pellicer A. Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome. Fertil. Steril. 2009; 92(6): 1803-10. https://dx.doi.Org/10.1016/j. fertnstert.2009.06.033.
  22. Reggia R., Sebbar H, Andreoli L. et al. Infertility and assisted reproductive technologies: a multicenter study in patients with SLE and APS. Clin. Exp. Rheumatol. 2016; 34(4, Suppl.99): P1:05, S-50. (10th European Lupus Meeting - Abstracts Venice, Italy - 5-8 October 2016)
  23. Henriksson P., Westerlund E., Wallen H., Brandt L., Hovatta O., Ekbom A. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ. 2015; 346: e8632. https://dx.doi. org/10.1136/bmj.e8632.
  24. Andreoli L., Bertsias G.K., Agmon-Levin N., Brown S., Cervera R., Costedoat-Chalumeau N. et al. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome, Ann. Rheum. Dis. 2017; 76(3): 476-85. https:// dx.doi.org/10.1136/annrheumdis-2016-209770.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

© Bionika Media, 2020

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>